PFIZER INC Proceeds from Short-term Debt
PFIZER INC (PFE) reported Proceeds from Short-term Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2026-02-26
- PFIZER INC proceeds from short-term debt for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC proceeds from short-term debt for the quarter ending 2025-09-28 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC proceeds from short-term debt for the quarter ending 2025-06-29 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC proceeds from short-term debt for the quarter ending 2025-03-30 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC proceeds from short-term debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PFIZER INC proceeds from short-term debt for fiscal 2024 was $8.91B, a 96.84% increase from fiscal 2023.
- PFIZER INC proceeds from short-term debt for fiscal 2023 was $4.53B, a 16.29% increase from fiscal 2022.
- PFIZER INC proceeds from short-term debt for fiscal 2022 was $3.89B.
| Period end | Proceeds from Short-term Debt 3 month | Proceeds from Short-term Debt 3 month as first filed | Proceeds from Short-term Debt 6 month | Proceeds from Short-term Debt 9 month | Proceeds from Short-term Debt 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $732.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $732.00M derived: sum of 3 quarters · filed 2026-02-26 | $2.89B derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-03-30 | $0.00 10-Q · filed 2025-05-05 | $732.00M derived: sum of 2 quarters · filed 2026-02-26 | $2.89B derived: sum of 3 quarters · filed 2026-02-26 | $7.46B derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | $732.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.89B derived: sum of 2 quarters · filed 2026-02-26 | $7.46B derived: sum of 3 quarters · filed 2026-02-26 | $8.91B 10-K · filed 2026-02-26 | |
| 2024-09-29 | $2.16B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $6.73B derived: sum of 2 quarters · filed 2025-11-04 | $8.18B 10-Q · filed 2025-11-04 | $12.69B derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $4.57B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $6.01B 10-Q · filed 2025-08-05 | $10.53B derived: sum of 3 quarters · filed 2026-02-26 | $10.53B derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $1.44B 10-Q · filed 2025-05-05 | $5.96B derived: sum of 2 quarters · filed 2026-02-26 | $5.96B derived: sum of 3 quarters · filed 2026-02-26 | $5.96B derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $4.51B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.51B derived: sum of 2 quarters · filed 2026-02-26 | $4.51B derived: sum of 3 quarters · filed 2026-02-26 | $4.53B 10-K · filed 2026-02-26 | |
| 2023-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $3.00M derived: sum of 2 quarters · filed 2024-11-04 | $14.00M 10-Q · filed 2024-11-04 | $18.00M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-07-02 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $14.00M 10-Q · filed 2024-08-05 | $18.00M derived: sum of 3 quarters · filed 2025-02-27 | -$107.00M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-04-02 | $11.00M 10-Q · filed 2024-05-08 | $15.00M derived: sum of 2 quarters · filed 2025-02-27 | -$110.00M derived: sum of 3 quarters · filed 2025-02-27 | $3.90B derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$121.00M derived: sum of 2 quarters · filed 2025-02-27 | $3.89B derived: sum of 3 quarters · filed 2025-02-27 | $3.89B 10-K · filed 2025-02-27 | |
| 2022-10-02 | -$125.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.89B derived: sum of 2 quarters · filed 2023-11-08 | $3.89B 10-Q · filed 2023-11-08 | $3.89B derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-07-03 | $4.01B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $4.01B 10-Q · filed 2023-08-09 | $4.01B derived: sum of 3 quarters · filed 2024-02-22 | $4.01B derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-04-03 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | |
| 2021-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-07-04 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-04-04 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $7.05B derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $7.05B derived: sum of 3 quarters · filed 2023-02-23 | $12.35B 10-K · filed 2023-02-23 | |
| 2020-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $7.05B derived: sum of 2 quarters · filed 2021-11-12 | $12.35B 10-Q · filed 2021-11-12 | $17.23B derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-28 | $7.05B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $12.35B 10-Q · filed 2021-08-12 | $17.23B derived: sum of 3 quarters · filed 2022-02-24 | $24.85B derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-29 | $5.30B 10-Q · filed 2021-05-13 | $10.18B derived: sum of 2 quarters · filed 2022-02-24 | $17.80B derived: sum of 3 quarters · filed 2022-02-24 | $21.15B derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $4.87B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $12.50B derived: sum of 2 quarters · filed 2022-02-24 | $15.85B derived: sum of 3 quarters · filed 2022-02-24 | $16.45B 10-K · filed 2022-02-24 | |
| 2019-09-29 | $7.63B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $10.97B derived: sum of 2 quarters · filed 2020-11-05 | $11.58B 10-Q · filed 2020-11-05 | $13.35B derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $3.35B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.96B 10-Q · filed 2020-08-06 | $5.72B derived: sum of 3 quarters · filed 2021-02-25 | $5.92B derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $609.00M 10-Q · filed 2020-05-07 | $2.38B derived: sum of 2 quarters · filed 2021-02-25 | $2.57B derived: sum of 3 quarters · filed 2021-02-25 | $3.89B derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $1.77B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.97B derived: sum of 2 quarters · filed 2021-02-25 | $3.28B derived: sum of 3 quarters · filed 2021-02-25 | $3.71B 10-K · filed 2021-02-25 | |
| 2018-09-30 | $199.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.52B derived: sum of 2 quarters · filed 2019-11-07 | $1.95B 10-Q · filed 2019-11-07 | $3.41B derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-07-01 | $1.32B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.75B 10-Q · filed 2019-08-08 | $3.21B derived: sum of 3 quarters · filed 2020-02-27 | $5.41B derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-04-01 | $428.00M 10-Q · filed 2019-05-09 | $1.89B derived: sum of 2 quarters · filed 2020-02-27 | $4.09B derived: sum of 3 quarters · filed 2020-02-27 | $6.34B derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $1.46B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $3.67B derived: sum of 2 quarters · filed 2020-02-27 | $5.91B derived: sum of 3 quarters · filed 2020-02-27 | $8.46B 10-K · filed 2020-02-27 | |
| 2017-10-01 | $2.20B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $4.45B derived: sum of 2 quarters · filed 2018-11-08 | $7.00B 10-Q · filed 2018-11-08 | $8.08B derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-07-02 | $2.25B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.80B 10-Q · filed 2018-08-09 | $5.87B derived: sum of 3 quarters · filed 2019-02-28 | $9.96B derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-04-02 | $2.55B 10-Q · filed 2018-05-10 | $3.63B derived: sum of 2 quarters · filed 2019-02-28 | $7.72B derived: sum of 3 quarters · filed 2019-02-28 | $9.34B derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $5.17B derived: sum of 2 quarters · filed 2019-02-28 | $6.79B derived: sum of 3 quarters · filed 2019-02-28 | $7.47B 10-K · filed 2019-02-28 | |
| 2016-10-02 | $4.09B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $5.71B derived: sum of 2 quarters · filed 2017-11-09 | $6.40B 10-Q · filed 2017-11-09 | $9.93B derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-07-03 | $1.63B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $2.31B 10-Q · filed 2017-08-10 | $5.84B derived: sum of 3 quarters · filed 2018-02-22 | $5.84B derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-04-03 | $682.00M 10-Q · filed 2017-05-11 | $4.22B derived: sum of 2 quarters · filed 2018-02-22 | $4.22B derived: sum of 3 quarters · filed 2018-02-22 | $4.24B derived: sum of 4 quarters · filed 2018-02-22 | |
| 2015-12-31 | $3.54B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $3.54B derived: sum of 2 quarters · filed 2018-02-22 | $3.56B derived: sum of 3 quarters · filed 2018-02-22 | $5.56B 10-K · filed 2018-02-22 | |
| 2015-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $23.00M derived: sum of 2 quarters · filed 2016-11-10 | $2.02B 10-Q · filed 2016-11-10 | $2.03B derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-06-28 | $23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $2.02B 10-Q · filed 2016-08-11 | $2.03B derived: sum of 3 quarters · filed 2017-02-23 | $2.03B derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-03-29 | $2.00B 10-Q · filed 2016-05-12 | $2.00B 10-Q · filed 2015-05-07 | $2.00B derived: sum of 2 quarters · filed 2017-02-23 | $2.01B derived: sum of 3 quarters · filed 2017-02-23 | $2.01B derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $12.00M derived: sum of 2 quarters · filed 2017-02-23 | $13.00M derived: sum of 3 quarters · filed 2017-02-23 | $13.00M 10-K · filed 2017-02-23 | |
| 2014-09-28 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $8.00M derived: sum of 2 quarters · filed 2015-11-05 | $8.00M 10-Q · filed 2015-11-05 | $608.00M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-29 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.00M 10-Q · filed 2015-08-06 | $601.00M derived: sum of 3 quarters · filed 2016-02-29 | $1.99B derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-30 | $0.00 10-Q · filed 2015-05-07 | $600.00M derived: sum of 2 quarters · filed 2016-02-29 | $1.99B derived: sum of 3 quarters · filed 2016-02-29 | $3.29B derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $600.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.99B derived: sum of 2 quarters · filed 2016-02-29 | $3.29B derived: sum of 3 quarters · filed 2016-02-29 | $4.32B 10-K · filed 2016-02-29 | |
| 2013-09-29 | $1.39B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $2.69B derived: sum of 2 quarters · filed 2014-11-06 | $3.72B 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | $1.30B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.33B 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | $1.03B 10-Q · filed 2014-05-08 | ||||
| 2012-12-31 | $8.00B 10-K · filed 2015-02-27 | ||||
| 2011-12-31 | $12.81B 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |